You, Jing
Yuan, Yidi
Gu, Xiaoxuan
Wang, Weihu
Li, Xiaofan
Funding for this research was provided by:
Beijing Hospitals Authority’s Ascent Plan (DFL20220902)
Clinical Trials Foundation of Peking University Cancer Hospital (QNJJ202108)
Article History
Received: 28 September 2023
Accepted: 24 June 2024
First Online: 12 July 2024
Declarations
:
: Ethical approval was obtained from the Ethics Committee of the Beijing Cancer Hospital (No: 2019YJZ27). This study was registered in the Chinese Clinical Trial Registry (registration number: ChiCTR1900024494, 13/07/2019). Written informed consent was obtained from all patients before participation.
: Written informed consent was obtained from all patients before participation.
: The authors declare no competing interests.